<DOC>
	<DOCNO>NCT01557348</DOCNO>
	<brief_summary>This multicenter , prospective , observational study ass efficacy MabThera/Rituxan ( rituximab ) alternative TNF-inhibitors patient rheumatoid arthritis non-responders intolerant single previous TNF-inhibitor . Data collect patient time change biologic therapy 12 month .</brief_summary>
	<brief_title>An Observational Study MabThera/Rituxan ( Rituximab ) Alternative TNF-Inhibitors Patients With Rheumatoid Arthritis Inadequate Response Single Previous TNF-Inhibitor</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Patients rheumatoid arthritis ( RA ) respond intolerant single TNFinhibitor therapy Initiated treatment MabThera/Rituxan alternative TNFinhibitor therapy , accordance relevant Summary Product Characteristics Patients whose second biologic therapy give part clinical trial study RA treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>